Biogenesis Bagó Inaugurated Its First Factory in Brazil. The New Unit Will Create 300 Job Openings, Focusing on Animal Vaccines.
Last Thursday, (04/07), Campo Largo, in the Metropolitan Region of Curitiba, marked a milestone for the animal health industry in Brazil. Biogenesis Bagó, a renowned Argentine company in veterinary biotechnology, inaugurated its first operation in the country with a new factory dedicated to the production of vaccines for pets and livestock. This venture not only strengthens the company’s presence in Latin America but also promises to significantly boost the local market with new job opportunities.
Biogenesis Bagó Factory and Strategic Expansion in Latin America
With a robust investment of R$ 100 million, the new Biogenesis Bagó factory in Campo Largo is designed to operate as a center of excellence in research, development, and production of biotechnological solutions for animal health.
The factory will occupy a built area of 4 thousand square meters and aspires to be a technological hub not only for vaccine production but also for the development of new products that meet the varied demands of the Brazilian market.
-
Anvisa orders the recall of Ypê products throughout Brazil after identifying a risk of contamination and serious manufacturing flaws.
-
The nuclear submarine that never arrives: The Álvaro Alberto project has accumulated 47 years of development, R$ 40 billion spent since 2008, and may now be delayed until 2037 due to a lack of R$ 1 billion in the Brazilian Navy’s coffers.
-
At 30, 40, or 50, starting over is no longer an exception: 7 high-demand areas in Brazil value experience, business acumen, and digital proficiency
-
Pork fat discarded by Brazilian meatpackers becomes an unexpected solution to replace petroleum-derived greases and lubricants, reducing friction by 54% in laboratory tests and raising an alert in a US$60 billion global market still dependent on mineral oil.
Creation of 300 New Job Openings
The arrival of Biogenesis Bagó in Brazil represents a milestone not only in terms of production capacity but also in job creation.
It is estimated that the new factory will create around 300 job openings, both direct and indirect, covering everything from production operators to research and development specialists.
This economic impact reflects the company’s commitment not only to establish itself locally but also to significantly contribute to the regional economy.
Strategic Partnerships and the Future of Biogenesis Bagó in Brazil
Initially, the factory will concentrate its activities on the production of essential vaccines for pets, such as the feline trivalent and various quintuple and sextuple options tailored to the specific needs of the Brazilian market.
In addition, the production of vaccines for livestock is planned, reinforcing Biogenesis Bagó’s commitment to serving both the pet market and agricultural production.
Despite its economic and industrial significance, the new unit will also serve as a technological hub to adapt Biogenesis Bagó’s products to meet the requirements of the Brazilian market.
The company’s Technological Development Department will play a crucial role in this process, ensuring that the biotechnological solutions offered align with the specific needs of different regions in Brazil.

Em João pessoa Pb está em falta vacina pra felinos
Em Colatina/ES existe uma fábrica da Bagó, sendo que o escritório da empresa situa-se no Rio de Janeiro/RJ. Não sei se é do mesmo grupo dessa Biogenesis, mas creio que sim. Neste caso, seria uma ampliação dos negócios da empresa no Brasil.
Eu gostaria de saber como conseguir uma vaga de emprego.